<bill session="107" type="hr" number="232" updated="2013-07-14T18:56:52-04:00">
  <state datetime="2001-08-02">REFERRED</state>
  <status>
    <introduced datetime="2001-08-02"/>
  </status>
  <introduced datetime="2001-08-02"/>
  <titles>
    <title as="introduced" type="official">Establishing a Select Committee on Medical Research.</title>
  </titles>
  <sponsor id="400393"/>
  <cosponsors/>
  <actions>
    <action state="REFERRED" datetime="2001-08-02">
      <text>Referred to the House Committee on Rules.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSRU" name="House Rules" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Congress"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Congressional committees (House)"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reorganization"/>
    <term name="Congressional reporting requirements"/>
    <term name="Economics and public finance"/>
    <term name="Federal aid to medical research"/>
    <term name="Government operations and politics"/>
    <term name="Government regulation"/>
    <term name="Health"/>
    <term name="House of Representatives"/>
    <term name="Intellectual property"/>
    <term name="Medical ethics"/>
    <term name="Medical research"/>
    <term name="Public-private partnerships"/>
    <term name="Research grants"/>
    <term name="Science, technology, communications"/>
  </subjects>
  <amendments/>
  <summary>8/2/2001--Introduced.
Establishes a select committee to be known as the Select Committee on Medical Research which shall conduct a thorough and complete study of: (1) the effectiveness of public and private (including universities, foundations, and industries) partnerships in the advancement and funding of medical research; (2) intellectual property issues arising from the advancement of medical research and research techniques; (3) ethical and social issues arising from advancements in medical research; (4) regulatory barriers to the performance of medical research and to the dissemination and application of research findings; and (5) other important issues relating to medical research.Requires a report from the committee to the House of Representatives.</summary>
</bill>
